Autopsy report · NCT01541072

Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation

“Number of enrolled patients was insufficient during planned inclusion time.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 7 months before it stopped.
• 34 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Centre Leon Berard

Sponsor type

University, hospital or other

Conditions

Non Hodgkin Lymphoma

Interventions

Pegfilgrastim; Filgrastim

Participants

34

Sites

2

Countries

France

Trials that died the same way

• African American Families Fighting Parental Cancer Together
  “Insufficient patients meet eligibility requirements.” (72% match in meaning)
• Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism
  “No patient corresponding to inclusion criteria couldn't be enrolled in the study” (70% match in meaning)
• Effect of Primidone on Platelet Responsiveness in Patients Determined to be Clopidogrel Resistant
  “Inclusion/Exclusion criteria was too stringent to enroll patients at this site.” (69% match in meaning)
• RCVS: The Rational Approach to Diagnosis and Treatment
  “Failure to recruit patients meeting inclusion criteria.” (69% match in meaning)
• Rehabilitation in Aortic Stenosis Patients
  “Slow inclusion rate, failure to recruit a priori determined no of patients.” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.